Apalutamide in the treatment of castrate-resistant prostate cancer: evidence from clinical trials

by Vadim S. Koshkin, Eric J. Small
Published 2018-12-01

Examining reporting and representation of patients with cancer in COVID‐19 clinical trials

by Maya Rabow, Christine Wang, Sylvia Zhang, Peggy Mary Tahir, Eric J. Small, Hala T. Borno
Published 2021-08-01

A bilingual, Internet-based, targeted advertising campaign for prostate cancer clinical trials: Assessing the feasibility, acceptability, and efficacy of a novel recruitment strate...

by Celia P. Kaplan, Adam Siegel, Yan Leykin, Nynikka R. Palmer, Hala Borno, Jessica Bielenberg, Jennifer Livaudais-Toman, Charles Ryan, Eric J. Small
Published 2018-12-01

Optimal MRI sequences for 68Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer

by Spencer T. Lake, Kirsten L. Greene, Antonio C. Westphalen, Spencer C. Behr, Ronald Zagoria, Eric J. Small, Peter R. Carroll, Thomas A. Hope
Published 2017-09-01

How current reporting practices may mask differences: A call for examining cancer-specific demographic enrollment patterns in cancer treatment clinical trials

by Hala T. Borno, Eric J. Small, Li Zhang, Mindy C. DeRouen, Ann Griffin, Joseph McGuire, Charles J. Ryan, Robert A. Hiatt, Celia P. Kaplan
Published 2019-12-01

A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance)

by Hyung L. Kim, Susan Halabi, Ping Li, Greg Mayhew, Jeff Simko, Andrew B. Nixon, Eric J. Small, Brian Rini, Michael J. Morris, Mary-Ellen Taplin, Daniel George
Published 2015-11-01

Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer

by Padmanee Sharma, Sumit Subudhi, James P Allison, Rahul Aggarwal, Eric J Small, Terence W Friedlander, Brandon Chen, Jaqueline Marquez, Kate Allaire, Alexander Cheung, Sharon Ng, Christopher Nguyen, Matthew Spitzer
Published 2021-05-01

Efficacy and safety of apalutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a subgroup analysis of a randomized, double-blind, placebo-controll...

by Hiroji Uemura, Takefumi Satoh, Hideyasu Tsumura, Gaku Arai, Keiichiro Imanaka, Kazuhiro Shibayama, Koji Fujii, Brendan Rooney, Angela Lopez-Gitlitz, Byron Espina, Carlos Perez-Ruixo, Eric J. Small, Matthew Smith
Published 2020-12-01

An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer

by Rajdeep Das, Martin Sjöström, Raunak Shrestha, Christopher Yogodzinski, Emily A. Egusa, Lisa N. Chesner, William S. Chen, Jonathan Chou, Donna K. Dang, Jason T. Swinderman, Alex Ge, Junjie T. Hua, Shaheen Kabir, David A. Quigley, Eric J. Small, Alan Ashworth, Felix Y. Feng, Luke A. Gilbert
Published 2021-07-01

Predicting cancer drug TARGETS - TreAtment Response Generalized Elastic-neT Signatures

by Nicholas R. Rydzewski, Erik Peterson, Joshua M. Lang, Menggang Yu, S. Laura Chang, Martin Sjöström, Hamza Bakhtiar, Gefei Song, Kyle T. Helzer, Matthew L. Bootsma, William S. Chen, Raunak M. Shrestha, Meng Zhang, David A. Quigley, Rahul Aggarwal, Eric J. Small, Daniel R. Wahl, Felix Y. Feng, Shuang G. Zhao
Published 2021-09-01

TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor

by Li Zhang, Divya Natesan, Lawrence Fong, Emily Chan, David Y Oh, Son Ho, Ivan de Kouchkovsky, Errol J Philip, Francis Wright, Daniel M Kim, Daniel Kwon, Hansen Ho, Sima P Porten, Anthony C Wong, Arpita Desai, Franklin W Huang, Jonathan Chou, Raj S Pruthi, Eric J Small, Terence W Friedlander, Vadim S Koshkin
Published 2021-05-01